In an α-syn preformed fibril (PFF)-induced mouse model of PD, our therapeutic strategy mediated robust human GBA1 transgene expression in the SN to significantly reduce α-syn aggregation/accumulation, preserve tyrosine hydroxylase-positive dopaminergic neurons, and mitigate neuroinflammation. This evidence concerns the gene GBA1 and Parkinson disease.